Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Fosfomycin is a bactericidal antibacterial indicated in the treatment of uncomplicated acute cystitis in adult women and adolescents. One to three time daily oral administration for one to three days. Possible intravenous administration.
It is excreted in human milk in insignificant amounts. (Kirby 1977)
Its use is approved in infants less than one year of age.
Its low oral bioavailability makes it difficult for the infant to pass into plasma from ingested mothers’ milk, except in premature infants and during the immediate neonatal period in which there may be greater intestinal permeability.
Food and calcium in the mothers’ milk make intestinal absorption even more difficult (Hale); calcium fosfomycin is very poorly absorbed. (Lebedevs 2020, Bergan 1990)
Although rare, the possibility of transient gastroenteritis due to altered intestinal flora should be considered in infants whose mothers take antibiotics. (Briggs 2015, Benyamini 2005)